tiprankstipranks
Trending News
More News >
ScanSource Inc (SCSC)
NASDAQ:SCSC

ScanSource (SCSC) AI Stock Analysis

Compare
141 Followers

Top Page

SCSC

ScanSource

(NASDAQ:SCSC)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$39.00
▲(1.59% Upside)
Action:ReiteratedDate:02/06/26
The score is supported by strong financial quality (notably the de-risked balance sheet and improved TTM performance) and a relatively low P/E. Offsetting factors are weak technicals with the stock trading below major moving averages and a more cautious near-term outlook after the guidance reset despite maintained free-cash-flow targets.
Positive Factors
De‑risked balance sheet
Extremely low reported debt and a debt-to-equity near 0.01 provide durable financial flexibility. This conservative capital structure reduces refinancing and liquidity risk, supports consistent buybacks and M&A optionality, and underpins resilience through economic cycles.
Strong free cash flow generation
High and improving free cash flow, with FCF roughly 0.91x net income, demonstrates the business converts earnings to cash sustainably. Persistent positive FCF supports reinvestment, dividends/buybacks, debt paydown, and strategic investments over the medium term.
High‑margin recurring Intelisys business
Intelisys contributes large, high‑margin recurring billings and attractive segment profitability. Its scale and margin profile diversify ScanSource away from low‑margin hardware distribution and provide a durable earnings and cash‑flow anchor as cloud adoption grows.
Negative Factors
Thin distribution margins
Distribution economics remain structurally low margin, leaving profitability highly sensitive to price pressure, product mix shifts, and volume swings. Limited margin buffer increases risk that modest adverse trends can erode earnings and free cash flow sustainability.
Historical cash‑flow cyclicality
Past episodes of negative operating and free cash flow show underlying sensitivity to end‑market cycles and working capital dynamics. While current FCF is strong, this volatility suggests less predictability across economic swings and higher monitoring of working capital risk.
Large‑deal timing & regional weakness
Dependence on lumpy large deals and exposure to challenging regional markets (Brazil decline, supplier losses) make revenue and margin visibility weaker. Timing variability in big contracts can depress near‑term billings and force conservative guidance, hindering planning.

ScanSource (SCSC) vs. SPDR S&P 500 ETF (SPY)

ScanSource Business Overview & Revenue Model

Company DescriptionScanSource, Inc. distributes technology products and solutions in the United States, Canada, and internationally. It operates through two segments, Specialty Technology Solutions and Modern Communications & Cloud. The Specialty Technology Solutions segment provides a portfolio of solutions primarily for enterprise mobile computing, data capture, barcode printing, point of sale (POS), payments, networking, electronic physical security, cyber security, and other technologies. This segment offers data capture and POS solutions to automate the collection, processing, and communication of information for commercial and industrial applications, including retail sales, distribution, shipping, inventory control, materials handling, warehouse management, and health care applications. It also provides electronic physical security products, such as identification, access control, video surveillance, intrusion-related, and wireless and networking infrastructure products. The Modern Communications & Cloud segment offers a portfolio of solutions primarily for communications technologies and services comprising voice, video conferencing, wireless, data networking, cable, unified communications and collaboration, cloud, and technology services, as well as IP networks and other solutions for various vertical markets, such as education, healthcare, and government. The company serves manufacturing, warehouse and distribution, retail and e-commerce, hospitality, transportation and logistics, government, education and healthcare, and other industries. ScanSource, Inc. was incorporated in 1992 and is headquartered in Greenville, South Carolina.
How the Company Makes MoneyScanSource generates revenue primarily through the distribution of technology products and solutions. Its revenue model is centered on purchasing products from manufacturers at wholesale prices and then reselling them to resellers and end-users at a markup. Key revenue streams include sales of hardware and accessories, software solutions, and related services such as training and technical support. The company also benefits from strong partnerships with leading manufacturers, which allows it to offer a diverse product portfolio and leverage joint marketing initiatives. Additionally, ScanSource's focus on value-added services, such as logistics and integration support, enhances its offering and contributes to recurring revenue streams, positioning it for sustainable growth in the technology distribution market.

ScanSource Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Neutral
The call presented a mix of steady operational and financial strengths (modest sales growth, strong Intelisys margins and billings, solid free cash flow, healthy balance sheet, accretive acquisitions, and a strategic go-to-market change) alongside tangible near-term headwinds (one-time period expenses, weaker large-deal invoicing/timing, a 9% decline in Brazil, and potential supply risk). Management lowered annual guidance relative to prior expectations but maintained free cash flow targets and emphasized confidence in multi-year strategic goals.
Q2-2026 Updates
Positive Updates
Modest Net Sales Growth
Company-wide Q2 net sales grew 3% year-over-year across both segments, with the Specialty Technology Solutions and Intelisys & Advisory segments each reporting 3% YoY sales growth.
Gross Profit and Margin Resilience
Gross profit increased 1% year-over-year for the quarter; Specialty Technology Solutions gross profit rose 1% YoY and would have been in line with revenue growth excluding ~30 basis points of period mix and freight costs.
Intelisys Strong Profitability and Billings
Intelisys & Advisory delivered gross profit growth of 3% YoY, an adjusted EBITDA margin of 41%, and annual net billings of approximately $2.85 billion.
Solid Free Cash Flow and Balance Sheet
The company generated strong free cash flow in the quarter, ended Q2 with approximately $83 million in cash, a net debt leverage ratio of ~0 (TTM adjusted EBITDA basis), and maintained free cash flow guidance of at least $80 million for the year.
Share Repurchase Activity and Capital Flexibility
Share repurchases totaled $18 million in the quarter with $179 million remaining under the repurchase authorization; closed a new five-year credit facility to support strategic objectives.
Strategic Investments and Acquisitions Contributing
Acquisitions (Advantix and DataZoom) and continued investment in Intelisys are contributing to growth and recurring revenue; recurring revenue represented ~18% of Specialty Technology Solutions gross profit for the quarter.
New Converged Communications Go-to-Market
Launched a unified converged communications sales team combining ScanSource hardware expertise and Intelisys cloud/CX capabilities to improve partner alignment and expand share of wallet in converging hardware-cloud solutions.
Strong Return Metrics
Adjusted ROIC was 11.9% for the quarter and 13.3% for the trailing year, indicating healthy returns on invested capital.
Negative Updates
Profitability Impact from Period Expenses
Profitability was negatively impacted by unexpected period expenses in Q2 (freight, unfavorable mix) and a customer-specific bad debt reserve, causing declines in gross profit and EBITDA margins versus a very strong prior quarter.
Specialty Technology Solutions Margin Pressure
Specialty Technology Solutions adjusted EBITDA margin was low at 2.8% for the quarter, with higher period expenses reducing the segment adjusted EBITDA margin by approximately 60 basis points.
Slower-than-Expected Large Deal Activity
Organic growth in the Specialty segment was slower than expected as large deals were often broken into smaller, more spread-out invoice events, reducing near-term billings and causing guidance revision risk if large deals do not resume.
Brazil Market Weakness
Brazil performance declined organically by 9% in the quarter; management cited a challenging distribution market and the loss of a supplier (Broadcom historically) as contributing factors to lower revenue in that region.
Supply/Component Risk (Memory Shortage)
Industry memory supply issues were noted as a potential risk that could lead to pricing pressure or shortages for suppliers; management indicated limited visibility and the potential for future impact.
Guidance Reset and Near-term Uncertainty
Management updated full-year guidance to $3.0B–$3.1B revenue and $140M–$150M adjusted EBITDA, signaling a more cautious near-term outlook driven by timing of large deals and period-related costs despite maintaining free cash flow expectations.
Company Guidance
ScanSource updated FY2026 guidance, now forecasting full-year revenue of $3.0–$3.1 billion and adjusted EBITDA of $140–$150 million while maintaining an annual free cash flow target of at least $80 million; this reflects first-half performance (gross profit margin close to 14% and adjusted EBITDA margin over 4.6%). In Q2, net sales grew 3% YoY in both segments and gross profit rose 1% YoY; Specialty net sales were +3% YoY (+4% QoQ), specialty adjusted EBITDA margin was 2.8% (impacted ~60 bps) and recurring revenues comprised ~18% of that segment’s gross profit (higher period costs reduced GP margin by ~30 bps). Intelisys annual net billings are ~$2.85 billion with a segment adjusted EBITDA margin of ~41%. The company ended Q2 with about $83 million in cash, net debt leverage of ~0x on trailing‑12‑month adjusted EBITDA, adjusted ROIC of 11.9% for the quarter (13.3% for the year), repurchased $18 million in the quarter (≈$40 million H1) with $179 million remaining authorization, and closed a new five‑year credit facility; management’s outlook assumes a second‑half pickup in large deals and continued Intelisys investment to convert faster‑growing new orders into future billings.

ScanSource Financial Statement Overview

Summary
Strong balance sheet with minimal debt (debt-to-equity ~0.01) and solid equity base supports resilience. TTM revenue rebound is significant (+63.3%) and profitability is steady but thin (net margin ~2.5%), leaving limited buffer if volumes soften. Free cash flow is currently strong and growing, but historical cash-flow volatility remains a key risk.
Income Statement
72
Positive
TTM (Trailing-Twelve-Months) revenue rebounded sharply (+63.3%) after two consecutive annual declines (2025: -6.7%, 2024: -13.9%), signaling a meaningful re-acceleration in demand. Profitability is steady but structurally thin: TTM gross margin is ~13.8% and net margin is ~2.5%, which is typical for distribution but leaves limited cushion if pricing or volumes soften. Operating profitability is consistent (TTM EBIT margin ~3.5%; EBITDA margin ~4.5%), with a modest improvement versus the 2025 annual period, but overall earnings power remains volume-dependent.
Balance Sheet
85
Very Positive
Leverage improved dramatically: total debt is very low in TTM ($2.9M) versus prior annual periods (e.g., ~$147M in 2025), driving an exceptionally conservative debt load (TTM debt-to-equity ~0.01). Equity remains solid (~$911M TTM) and returns on equity are stable in the high-single-digits (~8% TTM), reflecting consistent profitability without heavy balance-sheet risk. The main watch item is that returns are not high, implying the business generates respectable but not outsized shareholder returns despite the strong capital structure.
Cash Flow
66
Positive
Cash generation is positive in TTM with operating cash flow of ~$128M and free cash flow of ~$119M, and free cash flow growth is very strong (TTM +44.9%). Free cash flow broadly tracks earnings (TTM free cash flow is ~0.91x net income), indicating earnings quality is reasonable. However, cash flow has shown meaningful volatility historically (negative operating and free cash flow in 2022–2023, then a large rebound in 2024), so durability across cycles remains a key risk to monitor.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue3.02B3.04B3.26B3.79B3.53B3.15B
Gross Profit409.97M408.65M399.05M449.24M426.52M350.72M
EBITDA132.65M132.60M140.88M164.50M155.06M104.76M
Net Income73.89M71.55M77.06M89.81M88.80M10.79M
Balance Sheet
Total Assets1.74B1.79B1.78B2.07B1.94B1.67B
Cash, Cash Equivalents and Short-Term Investments83.47M126.16M185.46M36.18M37.99M62.72M
Total Debt120.59M147.11M153.96M343.58M288.75M164.01M
Total Liabilities830.78M879.20M854.78M1.16B1.13B940.49M
Stockholders Equity910.89M906.41M924.25M905.30M806.53M731.19M
Cash Flow
Free Cash Flow119.45M104.06M363.09M-45.75M-131.20M138.58M
Operating Cash Flow127.76M112.35M371.65M-35.77M-124.35M140.94M
Investing Cash Flow-26.67M-62.39M9.04M-8.26M-3.72M31.93M
Financing Cash Flow-131.81M-110.91M-227.77M39.53M108.11M-148.32M

ScanSource Technical Analysis

Technical Analysis Sentiment
Negative
Last Price38.39
Price Trends
50DMA
39.87
Negative
100DMA
40.68
Negative
200DMA
41.32
Negative
Market Momentum
MACD
-1.25
Positive
RSI
40.43
Neutral
STOCH
54.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCSC, the sentiment is Negative. The current price of 38.39 is below the 20-day moving average (MA) of 38.75, below the 50-day MA of 39.87, and below the 200-day MA of 41.32, indicating a bearish trend. The MACD of -1.25 indicates Positive momentum. The RSI at 40.43 is Neutral, neither overbought nor oversold. The STOCH value of 54.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SCSC.

ScanSource Risk Analysis

ScanSource disclosed 24 risk factors in its most recent earnings report. ScanSource reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ScanSource Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$1.52B18.419.30%1.02%3.19%-4.91%
71
Outperform
$5.48B27.414.71%2.77%-2.30%-29.75%
71
Outperform
$12.68B15.809.95%1.15%6.95%19.19%
67
Neutral
$777.38M11.348.16%-4.88%2.57%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$8.02B14.107.70%3.16%1.09%
59
Neutral
$2.57B16.509.20%-6.69%-51.74%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCSC
ScanSource
36.87
0.23
0.63%
ARW
Arrow Electronics
154.30
44.41
40.41%
AVT
Avnet
67.34
17.11
34.06%
NSIT
Insight Enterprises
81.93
-74.19
-47.52%
CNXN
PC Connection
60.81
-3.01
-4.71%
SNX
TD SYNNEX Corporation
158.22
20.41
14.81%

ScanSource Corporate Events

Business Operations and StrategyExecutive/Board ChangesStock BuybackFinancial Disclosures
ScanSource Posts Modest Q2 Growth and Governance Refresh
Neutral
Feb 5, 2026

On February 5, 2026, ScanSource reported results for the second quarter ended December 31, 2025, posting a 2.5% year-over-year increase in net sales to $766.5 million and a 1.2% rise in gross profit to $102.9 million, even as gross margin, operating income and non-GAAP profitability declined modestly. Recurring revenue grew 15.9% year-over-year and accounted for a larger share of gross profit, while adjusted EBITDA and non-GAAP net income fell compared with the prior-year period; the company generated strong operating and free cash flow, held modest net debt, and repurchased $38.7 million of shares during the first half of fiscal 2026. In a parallel move to refine its governance structure, the board appointed Charles A. Mathis as lead independent director and chair of the nominating and corporate governance committee, with Vernon J. Nagel taking over as audit committee chair, while longtime director Peter C. Browning remained on the board and all committees, signaling continuity alongside refreshed oversight for investors and other stakeholders.

The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
ScanSource discloses new direct financial obligation arrangement
Neutral
Dec 19, 2025

The filing excerpt from ScanSource provides only a cross-reference statement indicating that information disclosed in another section is incorporated by reference, without offering substantive details about the company’s operations, the nature of the transaction, or its impact on stakeholders.

The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.

Executive/Board ChangesShareholder Meetings
ScanSource Shareholders Approve Key Proposals at Annual Meeting
Neutral
Dec 9, 2025

On December 9, 2025, ScanSource, Inc. held its annual meeting of shareholders, where 90.5% of issued shares were represented. Shareholders approved the election of eight directors, the compensation of named executive officers, and the appointment of Deloitte & Touche LLP as independent auditors for fiscal 2026.

The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 06, 2026